| Identification | Back Directory | [Name]
L-Valine 5'-ester with 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one | [CAS]
956483-02-6 | [Synonyms]
L-Valine, 5'-ester with 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one
L-Valine 5'-ester with 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one | [Molecular Formula]
C27H35N3O6 | [MOL File]
956483-02-6.mol | [Molecular Weight]
497.58 |
| Chemical Properties | Back Directory | [Boiling point ]
667.3±65.0 °C(Predicted) | [density ]
1.33±0.1 g/cm3(Predicted) | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
13.74±0.60(Predicted) | [color ]
Off-White to Pale Yellow |
| Hazard Information | Back Directory | [Uses]
FV-100 is an orally available nucleoside analogue prodrug of CF-1743 (C291710) which is used for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. |
|
|